Afuco™ Anti-Human TMEM27 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-TMEM27 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibody directed to the protein TMEM27 is used for the treatment of type II diabetes (T2D).
Supplier Creative Biolabs
Product # AFC-595CL
Pricing Inquiry
Host Humanized
Target TMEM27
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback